Can Access Limits on Sales Representatives to Physicians Affect Clinical Prescription Decisions? A Study of Recent Events With Diabetes and Lipid Drugs

J Clin Hypertens (Greenwich). 2012; 14:435–446. ©2012 Wiley Periodicals, Inc. The authors explored to what extent important medical decisions by practitioners can be influenced by pharmaceutical representatives and, in particular, whether restricting such access could delay appropriate changes in cl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Chressanthis, George A., Khedkar, Pratap, Jain, Nitin, Poddar, Prashant, Seiders, Michael G.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108845/
https://ncbi.nlm.nih.gov/pubmed/22747616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2012.00651.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars